Christian Meier

Q: What Schools Are Affiliated With Christian Meier

Christian Meier is affiliated with the following schools: Heidelberg University, Saarland University, Humboldt University of Berlin, University of Freiburg, University of Göttingen, University of Cologne, University of Sydney, Ludwig Maximilian University of Munich, Ruhr University Bochum, University of Basel, University of Tübingen

Christian Meier 's AcademicInfluence.com Rankings

Christian Meier

History

#1463

World Rank

#2199

Historical Rank

Ancient History

#40

World Rank

#62

Historical Rank

history Degrees

Download Badge

History

Why Is Christian Meier Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Christian Meier is a German historian and professor emeritus of ancient history at the University of Munich. In 2002, Meier was awarded the Austrian Decoration for Science and Art. He is also a member of the Norwegian Academy of Science and Letters.

(See a Problem?)

Christian Meier 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia (2008) (426)
TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). (2001) (399)
Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. (2002) (386)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer (2010) (379)
Use of thiazolidinediones and fracture risk. (2008) (354)
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. (2008) (248)
Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. (2003) (244)
Supplementation With Oral Vitamin D3 and Calcium During Winter Prevents Seasonal Bone Loss: A Randomized Controlled Open‐Label Prospective Trial (2004) (200)
Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study (2004) (159)
Use of metformin and the risk of ovarian cancer: a case-control analysis. (2011) (151)
Effects of diabetes drugs on the skeleton. (2016) (134)
Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. (2007) (131)
Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis (2012) (124)
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial. (2016) (123)
Parathyroid hormone analogues in the treatment of osteoporosis (2011) (121)
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. (2020) (111)
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors (2017) (105)
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2 (2016) (102)
Antiepileptics and bone health (2011) (101)
Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case–Control Analysis (2011) (100)
Use of depot medroxyprogesterone acetate and fracture risk. (2010) (84)
Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis. (2003) (80)
Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. (2002) (65)
Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. (2006) (62)
Possible beneficial effect of bisphosphonates in osteonecrosis of the knee (2010) (58)
Ubiquitin‐Associated Domain Mutations of SQSTM1 in Paget's Disease of Bone: Evidence for a Founder Effect in Patients of British Descent (2004) (56)
Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial (2004) (55)
Procalcitonin levels predict clinical course and progression‐free survival in patients with medullary thyroid cancer (2009) (55)
Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey (2003) (53)
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial (2013) (53)
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (2019) (53)
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial (2013) (53)
Is there a clinical relevance of partial androgen deficiency of the aging male? (2004) (51)
Effect of restoration of euthyroidism on peripheral blood cells and erythropoietin in women with subclinical hypothyroidism. (2003) (44)
Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. (2009) (41)
Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. (2019) (41)
External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients. (2017) (41)
Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. (2008) (40)
Use of Bone Turnover Markers in the Real World: Are We There Yet? (2009) (39)
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. (2021) (38)
l-Carnitine and the recovery from exhaustive endurance exercise: a randomised, double-blind, placebo-controlled trial (2005) (37)
CA-125 serum concentrations during the menstrual cycle. (1988) (37)
Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature. (2014) (36)
Endocrine regulation of bone turnover in men (2005) (36)
Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. (2004) (36)
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. (2017) (36)
Risk of Fractures with Glitazones (2009) (36)
Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice (2013) (34)
Bone mineral density and its determinants in men with opioid dependence (2015) (30)
Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. (2005) (28)
Bone turnover in elderly men: relationships to change in bone mineral density (2007) (28)
Comparison of different methods for the measurement of serum testosterone in the aging male. (2004) (28)
Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. (2020) (27)
REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival. (2017) (27)
Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms (2016) (26)
Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older (2013) (25)
Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice (2009) (25)
Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society. (2019) (23)
Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men. (2005) (23)
Calcium supplementation, osteoporosis and cardiovascular disease. (2011) (22)
Prolactin dysregulation in women with subclinical hypothyroidism: effect of levothyroxine replacement therapy. (2003) (22)
The role of teriparatide in sequential and combination therapy of osteoporosis. (2014) (22)
Updating clinical endpoint definitions (2013) (22)
Before and after hip fracture, vitamin D deficiency may not be treated sufficiently (2013) (22)
Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health (2016) (21)
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis (2019) (21)
Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study (2015) (21)
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). (2020) (20)
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study (2017) (20)
Changes in Liver Function correlate with the Improvement of Lipid Profileafter Restoration of Euthyroidism in Patients with Subclinical Hypothyroidism (2004) (19)
Soluble guanylate cyclase stimulators and activators: Past, present and future. (2021) (19)
REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat. (2017) (19)
Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease (2017) (19)
Metformin and breast cancer risk Long-term metformin use is associated with decreased risk of breast cancer Short title : Metformin and breast cancer risk (2010) (18)
The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study (2016) (17)
Basal TSH levels compared with TRH‐stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performance (2002) (17)
Proton Pump Inhibitors and Fracture Risk (2010) (16)
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry. (2020) (16)
A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767] (2017) (15)
Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. (2009) (14)
Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS). (2021) (13)
Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study (2019) (12)
Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study. (2016) (12)
Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials (2019) (11)
Bone Microarchitecture and Strength in Long‐Standing Type 1 Diabetes (2022) (11)
Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee (2019) (11)
Biochemical Markers of Bone Turnover – Basic Biochemistry and Variability (2010) (11)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications (2017) (10)
Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study. (2000) (9)
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. (2022) (9)
Monitoring of Antiresorptive Therapy (2006) (8)
Effect of l-Thyroxine Replacement Therapy on Surrogate Markers of Skeletal and Cardiac Function in Subclinical Hypothyroidism (2004) (8)
Seasonal Variation of Bone Turnover? (2003) (7)
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry. (2020) (7)
[Long-term study of subclinical hypothyroidism: spontaneous course and predictors of manifest hypothyroidism]. (1998) (7)
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison (2016) (6)
Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion? (2005) (6)
Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: reassessment of the hCG stimulation test. (2005) (6)
Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy (2018) (6)
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension (2020) (6)
Late Breaking Abstract - Switching from PDE5i to riociguat in patients with PAH: The REPLACE study (2020) (5)
[Is there a need for treatment in subclinical hypo- and hyperthyroidism?]. (1999) (5)
Biochemical Markers of Bone Turnover – Clinical Aspects (2010) (5)
Application of the REVEAL risk score calculator 2.0 in the PATENT study. (2021) (5)
Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study (2018) (5)
Gynaecologists' awareness of bone healthcare in Switzerland. (2014) (5)
High Impact Physical Activity and Bone Health of Lower Extremities in Childhood Cancer Survivors: A Cross-sectional Study of SURfit. (2020) (4)
REPLACE: A prospective, randomized trial of riociguat replacing phosphodiesterase 5 inhibitor therapy in patients with pulmonary arterial hypertension who are not at treatment goal (2017) (4)
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry (2015) (4)
Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co‐medication: a population‐based observational study (2016) (4)
Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study (2019) (3)
CHAPTER 39 – Monitoring of Antiresorptive Therapy (2006) (3)
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. (2021) (3)
Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer (2006) (3)
[Osteoporosis: evaluation, diagnosis and monitoring]. (2012) (3)
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study (2020) (3)
Chapter 16 – Sex Steroids and Skeletal Health in Men (2006) (3)
Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry (2016) (3)
Safety of Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension: Final Data Cut from the EXPERT Registry (2019) (3)
Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study. (2020) (3)
The influence of gonadal hormones on skeletal health in men (2013) (3)
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. (2020) (3)
Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study (2022) (3)
Variability in the Measurement of Biochemical Markers of Bone Turnover (2006) (3)
[Thiazolidinediones and skeletal health]. (2009) (2)
[Perioperative risk assessment of geriatric patients undergoing noncardiac surgery]. (2014) (2)
Association between glycemic control and risk of venous thromboembolism in diabetic patients: A nested case-control study (2021) (2)
Safety of Riociguat for the Treatment of Pulmonary Arterial Hypertension: Final Data Cut from the EXPERT Registry (2019) (2)
Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD) (2015) (2)
[Thiazolidinediones and skeletal health]. (2009) (2)
Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies) (2020) (2)
Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart Function (2018) (2)
Gonadal hormones and their influence on skeletal health in men (2007) (2)
Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women? (2007) (2)
Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey (2022) (2)
Effect of Hyponatremia Normalization on Osteoblast Function in Patients with SIAD. (2021) (2)
The Relationship Between NO Pathway Biomarkers and Response to Riociguat in the RESPITE Study of Patients With PAH Not Reaching Treatment Goals With Phosphodiesterase 5 Inhibitors (2016) (1)
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study. (2021) (1)
[Clinical value of C-peptide determination]. (1997) (1)
[Laboratory investigation of endocrine function - interpretation of results and pitfalls]. (2013) (1)
[Primary hyperparathyroidism]. (2011) (1)
Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit) (2022) (1)
Markers of Bone Remodeling and the Aging Skeleton (2010) (1)
[Ultrasensitive TSH screening for detection of thyroid gland dysfunctions in women of a medical ambulatory care patient group]. (1998) (1)
CHAPTER 34 – Variability in the Measurement of Biochemical Markers of Bone Turnover (2006) (1)
SWITCHING TO RIOCIGUAT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION NOT AT TREATMENT GOAL WITH PHOSPHODIESTERASE TYPE-5 INHIBITORS: SUBGROUP ANALYSIS RESULTS OF THE REPLACE STUDY (2020) (1)
Use ofMetformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case–Control Analysis (2012) (1)
Chapter 35 – Testicular Dysfunction (2010) (1)
Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. (2016) (1)
Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study (2017) (1)
Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH (2022) (1)
[Mental changes in hypo- and hyperthyroidism]. (2002) (1)
Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study. (2020) (1)
Effects of a hypervolemic hemodilution with HES 100/0.5 10% in patients with PAOD stage II: Elimination kinetics and blood fluidity (1996) (1)
Current status on 25(OH) vitamin D measurement, target levels and supplementation (2015) (0)
Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism: A Randomized Double-Blind, Placebo-Controlled Trial (2004) (0)
Swiss primary hyperparathyroidism cohort study (2009) (0)
Application of the REVEAL risk score calculator 2.0 in the CHEST study. (2022) (0)
Analysis of Risk Assessment Tools in the REPLACE Study (2021) (0)
Personalised immunomodulating treatments for Graves' disease: fact or fiction? (2017) (0)
Hypothyroidism Subclinical: Encyclopedia of Endocrinology and Endocrine Diseases (2014) (0)
Effects of Supplemental Glucose and Bicarbonate for Promoting Recovery During Swim Training (2017) (0)
[Osteoporosis: diagnostic assessment]. (2009) (0)
[In Process Citation]. (2014) (0)
Benefits and place of calcimimetics in the management of primary hyperparathyroidism. (2015) (0)
EFFECT OF RIOCIGUAT ON RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2018) (0)
Faculty Opinions recommendation of Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. (2007) (0)
Application of REVEAL Risk Score to Patients With PAH Receiving Riociguat in the PATENT-2 Study (2015) (0)
Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients. (2020) (0)
The Relationship of Hemodynamics and Exercise Capacity With Response to Riociguat Therapy in the Respite Study of PAH Patients With an Insufficient Response to Phosphodiesterase 5 Inhibitors (2017) (0)
COMPARISON OF RISK DISCRIMINATION BETWEEN REVEAL RISK SCORE CALCULATORS IN PATIENTS FROM THE PATENT STUDIES OF RIOCIGUAT IN PULMONARY ARTERIAL HYPERTENSION (2020) (0)
Atypical femoral fractures – three case reports – subclassification of “atypical atypical femoral fractures” (2016) (0)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Committee of Scientific Advisory Abstracts (2021) (0)
Capture the fracture by SMS (2016) (0)
[FLS - three letters alter secondary fracture prevention]. (2016) (0)
[In Process Citation]. (2014) (0)
Evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism belonging to the Swiss primary hyperparathyroidism cohort (2011) (0)
Normalization of SIAD-induced hyponatremia stimulates osteoblast function (2021) (0)
A data-driven approach to identify clusters of HbA1c longitudinal trajectories and associated 2 outcomes in type 2 diabetes mellitus: a large population-based cohort study (2022) (0)
An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD. (2023) (0)
Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study. (2020) (0)
A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767] (2017) (0)
Bone microarchitecture in patients with long-standing type 1 diabetes (2021) (0)
IMPACT OF BASELINE RISK STATUS ON OUTCOMES IN THE REPLACE STUDY (2021) (0)
Update Osteoporose (2021) (0)
Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 study (2015) (0)
Plasma Sodium Increase Is Associated With an Increase in Bone Formation in Outpatients With Chronic SIAD - A Predefined Secondary Analysis of the SANDx Trial (2023) (0)
Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience (2021) (0)
Results of Early Thyroidectomy and Prognostic Value of Codon Analysis Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic (2013) (0)
EFFECT OF RIOCIGUAT ON RIGHT VENTRICULAR FUNCTION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2018) (0)
Experience with cinacalcet in primary hyperparathyroidism: results from the Swiss primary hyperparathyroidism cohort study (2009) (0)
Safety of riociguat for the treatment of pulmonary hypertension: Data from the EXPERT registry (2017) (0)

This paper list is powered by the following services:

Other Resources About Christian Meier

en.wikipedia.org

What Schools Are Affiliated With Christian Meier ?

Christian Meier is affiliated with the following schools:

Christian Meier 's Academic­Influence.com Rankings